X
HIV drug cuts viral load, boosts immunity in Yale study
https://pharmaphorum.com/news/ibalizumab-cuts-hiv-viral-load/
HIV/AIDS
AbiVax claims progress towards HIV cure
French biotech to step up clinical development of ABX464.
Landmark HIV prophylaxis trial to begin next month
Trial involves generics supplied by Mylan.
Gilead’s latest hep C combo approved in US
Vosevi is aimed at tough to treat patients.
Stop obsessing about generic Advair, says GSK’s Witty
Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
Facebook chatbot to help pregnant women in South Africa
The service will provide a live helpdesk for expectant mothers.
NHS refuses to fund HIV prophylaxis – again
Decision branded “shameful” by HIV campaigners.
